CSL in development of blood-derived Covid-19 treatment

Biotechnology giant CSL has begun development of a blood-derived treatment for Covid-19, known as COVID-19 Immunoglobulin. The Melbourne company believes the product could be used to treat people seriously ill with the complications caused by the virus, particularly those whose illness is progressing towards the need for ventilation. The treatment will be derived from blood…

Archer in quantum deal with IBM

New materials technology developer Archer Materials has signed an agreement with computing giant IBM to advance their quantum computing ambitions. The company, which is progressing development of a quantum computing chip, has joined the global IBM Q Network as an ‘ecosystem partner’. Archer’s chip, known as the CQ qubit processor, will now utilise IBM’s open…